Snrna rnu2-1 as a tumor marker
OwnerWolff Schmiegel, Alexander Baraniskin +1inventors
InventorsWolff Schmiegel, Alexander Baraniskin, Stephan Hahn
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the diagnosis of malignant diseases comprising the steps Provision of a sample obtained from a bodily fluid or bodily excretion as well as Determination of the concentration of snRNA RNU2-1 or their fragments in the sample, as well as a kit for the performance of this diagnosis, and the use of probes specific to RNU2-1 and fragments thereof.
Claims15
Method for diagnosis of malignant diseases comprising the steps
- Provision of a sample obtained from a bodily fluid or bodily excretion as well as
- Determination of the concentration of snRNA RNU2-1 and/or their fragments in the sample.
Kit for the diagnosis of malignant diseases, comprising at least one probe and/or one primer for the detection of at least one, in particular all of the fragments SEQ2 to SEQ10.
Use of probes specific to SEQ4 (miR-1246) for the diagnosis of cancer diseases.
Use of the snRNA RNU2-1, fragments thereof and preferably at least one, in particular the entirety of the fragments SEQ2 to SEQ10 for the diagnosis of cancer diseases.
Dependencies are inferred from the claim text.